3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Glioblastoma
11
Brain Neoplasms
11
Gliosarcoma
9
Neuroblastoma
5
Astrocytoma
5
Oligodendroglioma
4
Glioma
4
Carcinoma, Renal Cell
4
Sarcoma, Ewing
3
Sarcoma
3
Rhabdomyosarcoma
3
Rhabdoid Tumor
3
Recurrence
3
Neoplasms, Germ Cell and Embryonal
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Wilms Tumor
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neurofibromatosis 2
2
Neurofibromatosis 1
2
Neoplasms
2
Melanoma
2
Medulloblastoma
2
Ependymoma
2
Carcinoma, Hepatocellular
2
Vestibulocochlear Nerve Diseases
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Granulocyte Colony-Stimulating Factor
5
Melphalan
4
Cyclophosphamide
4
Biopsy
4
Thiotepa
3
Mesna
3
Filgrastim
3
Etoposide
3
Busulfan
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
Vemurafenib
2
Temozolomide
2
Peripheral Blood Stem Cell Transplantation
2
Nivolumab
2
LY3023414
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
Sirolimus
×
CNS
×
Clear all
NCT01331135
2020-05-29
Aflac ST0901
Emory University
Phase 1
Completed
18 enrolled